Chimerix Inc (NASDAQ:CMRX) - Share price - Overview

Stock Report

Chimerix Inc CMRX

Last Price
$6.40

Day Change
-0.06|-0.93%

As of 27/03/2017
16:00:00 EDT | USD
Minimum 15 Minutes Delay.

Last Close6.46
Day Range6.07 - 6.49
Mkt Cap-
52-Wk Range3.50 - 6.64
Yield %-
ISINUS16934W1062
Volume393,911
P/E-3.88
P/S51.89
P/CF-4.64

Share Price

Financials
201420152016
More ...
Income Statement
Revenue4.0410.765.70
Operating Income-58.87-118.25-77.95
Net Income-59.31-117.37-76.39
Basic EPS-1.80-2.67-1.65
Avg. Diluted Shares Outstanding334446
Balance Sheet
Current Assets237.46228.84236.47
Non Current Assets54.42127.1650.31
Total Assets291.88355.99286.77
Current Liabilities17.0720.1810.11
Total Liabilities17.2420.5310.55
Total Equity274.64335.46276.22
Cash Flow
Operating Cash Flow-47.08-99.89-63.82
Capital Expenditure-1.02-2.21-0.84
Free Cash Flow-48.10-102.10-64.66

In millions, except "Basic EPS". Currency is USD.

Company Profile

Chimerix Inc is a biotechnology company that develops and commercializes oral antivirals. Its compounds include brincidofovir (BCV, CMX001).

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

87
Key Stats
More ...
Price/Earning TTM-3.92
Price/Book1.09
Price/Sales TTM43.68
Rev Growth (3 year avg)9.27
EPS Growth (3 year avg)-
Operating Margin % TTM-1,367.10
Net Margin % TTM-1,339.71
ROE TTM-24.98
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.